Titre
Das Antiarrhythmikum Chinidin als Alternative in der Behandlung der schweren Falciparum-Malaria. [The anti-arrhythmia drug quinidine as an alternative in the treatment of severe falciparum malaria]
Type
étude de cas
Institution
Externe
Périodique
Auteur(s)
Ris, H. B.
Auteure/Auteur
Stahel, E.
Auteure/Auteur
Pittet, J. F.
Auteure/Auteur
Friedemann, M.
Auteure/Auteur
Liens vers les personnes
ISSN
0036-7672
Statut éditorial
Publié
Date de publication
1983-02
Volume
113
Numéro
7
Première page
254
Dernière page/numéro d’article
8
Notes
Case Reports
English Abstract
Journal Article --- Old url value: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6340187 --- Old month value: Feb 19
English Abstract
Journal Article --- Old url value: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6340187 --- Old month value: Feb 19
Résumé
Parenteral quinine is the most effective treatment for severe falciparum malaria. It is not easily available in Switzerland and so dangerous delays treating patients may occur. The antiarrhythmic drug quinidine, usually stocked by hospitals, is an alternative drug for malaria treatment. We report the cases of two patients with severe malaria imported from Kenya. They were treated first with intravenous quinidine sulfate over 3 days and for another 4 days with peroral quinidine sulfate. The therapeutic response was excellent. During the 2 months posttherapeutic period no recrudescence of Plasmodium falciparum occurred. 20 mg/kg b.w./die of quinidine given intravenously seems to be an adequate dose in severe falciparum malaria.
Sujets
PID Serval
serval:BIB_BB34BBC79F44
PMID
Date de création
2008-01-29T12:00:02.311Z
Date de création dans IRIS
2025-05-21T04:53:33Z